Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
90%
OVERLAP
BY WEIGHT
310
# OF OVERLAPPING
HOLDINGS
VHT
411
HOLDINGS
82%
ALSO IN FHLC
FHLC
349
HOLDINGS
96%
ALSO IN VHT
SECTOR DRIFT (VHT minus FHLC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.9% | 11.3% | 9.9% |
|
ABBVIE INC | 5.4% | 6.1% | 5.4% |
|
JOHNSON & JOHNSON | 5.2% | 6.4% | 5.2% |
|
UNITEDHEALTH GROUP INC | 4.8% | 7.3% | 4.8% |
|
ABBOTT LABORATORIES | 4.0% | 3.8% | 3.8% |
VHT Overweight Relative to FHLC
|
ALNYLAM PHARMACEUTICALS INC | 0.5% |
|
BOSTON SCIENTIFIC CORP | 0.4% |
|
IDEXX LABORATORIES INC | 0.3% |
|
HCA HOLDINGS INC | 0.3% |
|
STRYKER CORP | 0.2% |
|
CENCORA INC | 0.2% |
|
INSMED INC | 0.2% |
|
CVS CAREMARK CORP | 0.2% |
|
RESMED INC | 0.2% |
|
MCKESSON CORP | 0.2% |
VHT Underweight Relative to FHLC
|
UNITEDHEALTH GROUP INC | -2.5% |
|
ELI LILLY & CO | -1.4% |
|
JOHNSON & JOHNSON | -1.3% |
|
ABBVIE INC | -0.7% |
|
BRISTOL-MYERS SQUIBB CO | -0.3% |
|
ELEVANCE HEALTH INC | -0.3% |
|
VERTEX PHARMACEUTICALS INC | -0.3% |
|
CENTENE CORP | -0.2% |
|
INTRA-CELLULAR THERAPIES INC | -0.2% |
|
REGENERON PHARMACEUTICALS | -0.1% |